Home › Funds › Frazier Life Sciences Management, L.P. › PBLS
Frazier Life Sciences Management, L.P. position in PBLS
PARABILIS MEDICINES INC · Health Care
Frazier Life Sciences Management, L.P. reported holding 1,920,805 shares of PBLS (PARABILIS MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$52.6M, representing 1.14% of its reported portfolio and ranking #17 among its reported holdings. Frazier Life Sciences Management, L.P. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Frazier Life Sciences Management, L.P.'s PBLS position evolved
Frazier Life Sciences Management, L.P. first disclosed a stake in PBLS in Q2 2026 at 1,920,805 shares (US$52.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.92M | $52.57M | New |
About PBLS and 13F data
PBLS (PARABILIS MEDICINES INC) is a Health Care company. 89 other funds we track also report a position in PBLS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$791.9M), ARCH Venture Management, LLC (US$175.5M), venBio Partners LLC (US$144.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PBLS
- RA CAPITAL MANAGEMENT, L.P. 28.93M sh · $791.91M · Q2 2026
- ARCH Venture Management, LLC 6.41M sh · $175.52M · Q2 2026
- venBio Partners LLC 5.27M sh · $144.15M · Q2 2026
- Alphabet Inc. 4.92M sh · $134.65M · Q2 2026
- Nextech Invest Ltd. 4.66M sh · $127.63M · Q2 2026
- Cormorant Asset Management, LP 4.62M sh · $126.33M · Q2 2026
- REGENERON PHARMACEUTICALS, INC. 4.17M sh · $114.04M · Q2 2026
- Siren, L.L.C. 2.99M sh · $81.90M · Q2 2026
- Farallon Capital Management 2.37M sh · $64.82M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.37M sh · $64.82M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.88M sh · $51.47M · Q2 2026
- General Catalyst Group Management, LLC 1.60M sh · $43.82M · Q2 2026
More on Frazier Life Sciences Management, L.P.
FAQ
How long has Frazier Life Sciences Management, L.P. held PBLS?
Frazier Life Sciences Management, L.P. has disclosed PBLS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Frazier Life Sciences Management, L.P.'s current position in PBLS?
As of Q2 2026, Frazier Life Sciences Management, L.P. holds 1.92M shares of PBLS (PARABILIS MEDICINES INC), valued at $52.57M, representing 1.14% of its reported portfolio and ranking #17.
Has Frazier Life Sciences Management, L.P. been buying or selling PBLS?
In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. newly opened its position in PBLS.
Which other funds hold PBLS?
Other major institutional holders of PBLS include RA CAPITAL MANAGEMENT, L.P., ARCH Venture Management, LLC, venBio Partners LLC, among 89 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.